Mabs | www.gmachineinfo.com | 全球机械文献资源网

OA期刊

ISSN	1942-0862
刊名	Mabs
出版商	Taylor & Francis Inc.
url	https://www.tandfonline.com/loi/kmab20
机构	Taylor & Francis Ltd.

全部

2010	2011	2012	2013	2014	2015
2016	2017	2018	2019	2020	2021
2022	2023	2024	2025

2021, vol.13, no.1

题名

作者

出版年

年卷期

In memoriam: Jefferson Foote

E. Sally Ward;Peter Jones;Tim Buss;Cristina Rada;Gregory Winter;Richard Willson;

2021

2021, vol.13, no.1

Common light chain chickens produce human antibodies of high affinity and broad epitope coverage for the engineering of bispecifics

Kathryn H. Ching;Kimberley Berg;Kevin Reynolds;Darlene Pedersen;Alba Macias;Yasmina N. Abdiche;William D. Harriman;Philip A. Leighton;

2021

2021, vol.13, no.1

Bispecific antibody target pair discovery by high-throughput phenotypic screening using in vitro combinatorial Fab libraries

Pallavi Bhatta;Kevin D. Whale;Amy K. Sawtell;Clare L. Thompson;Stephen E. Rapecki;David A. Cook;Breda M. Twomey;Milena Mennecozzi;Laura E. Starkie;Emily M. C. Barry;Shirley J. Peters;Ahmad M. Kamal;Helene M. Finney;

2021

2021, vol.13, no.1

Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor response

Josefa Dela Cruz Chuh;MaryAnn Go;Yvonne Chen;Jun Guo;Hanine Rafidi;Danielle Mandikian;Yonglian Sun;Zhonghua Lin;Kellen Schneider;Pamela Zhang;Rajesh Vij;Danielle Sharpnack;Pamela Chan;Cecile de la Cruz;Jack Sadowsky;Dhaya Seshasayee;James T. Koerber;Thomas H. Pillow;Gail D. Phillips;Rebecca K Rowntree;C. Andrew Boswell;Katherine R. Kozak;Andrew G. Polson;Paul Polakis;Shang-Fan Yu;Peter S. Dragovich;Nicholas J. Agard;

2021

2021, vol.13, no.1

Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn in vitro and in vivo

Simone Mester;Mitchell Evers;Saskia Meyer;Jeannette Nilsen;Victor Greiff;Inger Sandlie;Jeanette Leusen;Jan Terje Andersen;

2021

2021, vol.13, no.1

Activity of murine surrogate antibodies for durvalumab and tremelimumab lacking effector function and the ability to deplete regulatory T cells in mouse models of cancer

Darren J. Schofield;Jennifer Percival-Alwyn;Mateusz Rytelewski;John Hood;Raymond Rothstein;Leslie Wetzel;Kelly McGlinchey;Grace Adjei;Amanda Watkins;LeeAnn Machiesky;Weimin Chen;John Andrews;Maria Groves;Michelle Morrow;Ross A. Stewart;Andrew Leinster;Robert W. Wilkinson;Scott A. Hammond;Nadia Luheshi;Claire Dobson;Michael Oberst;

2021

2021, vol.13, no.1

A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3

Alexander Rau;Katharina Kocher;Mirjam Rommel;Lennart Kühl;Maximilian Albrecht;Hannes Gotthard;Nadine Aschmoneit;Bettina Noll;Monilola A. Olayioye;Roland E. Kontermann;Oliver Seifert;

2021

2021, vol.13, no.1

Rational selection of building blocks for the assembly of bispecific antibodies

Danyang Gong;Timothy P. Riley;Krzysztof P. Bzymek;Ana R. Correia;Danqing Li;Christopher Spahr;John H. Robinson;Ryan B. Case;Zhulun Wang;Fernando Garces;

2021

2021, vol.13, no.1

Antibodies to watch in 2021

Hélène Kaplon;Janice M. Reichert;

2021

2021, vol.13, no.1

Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2

Shion A. Lim;Josef A. Gramespacher;Katarina Pance;Nicholas J. Rettko;Paige Solomon;Jing Jin;Irene Lui;Susanna K. Elledge;Jia Liu;Colton J. Bracken;Graham Simmons;Xin X. Zhou;Kevin K. Leung;James A. Wells;

2021

2021, vol.13, no.1